Literature DB >> 23727437

Adaptations in AMPA receptor transmission in the nucleus accumbens contributing to incubation of cocaine craving.

Jessica A Loweth1, Kuei Y Tseng, Marina E Wolf.   

Abstract

Cue-induced cocaine craving in rodents intensifies or "incubates" during the first months of withdrawal from long access cocaine self-administration. This incubation phenomenon is relevant to human users who achieve abstinence but exhibit persistent vulnerability to cue-induced relapse. It is well established that incubation of cocaine craving involves complex neuronal circuits. Here we will focus on neuroadaptations in the nucleus accumbens (NAc), a region of convergence for pathways that control cocaine seeking. A key adaptation is a delayed (~3-4 weeks) accumulation of Ca(2+)-permeable AMPAR receptors (CP-AMPARs) in synapses on medium spiny neurons (MSN) of the NAc. These CP-AMPARs mediate the expression of incubation after prolonged withdrawal, although different mechanisms must be responsible during the first weeks of withdrawal, prior to CP-AMPAR accumulation. The cascade of events leading to CP-AMPAR accumulation is still unclear. However, several candidate mechanisms have been identified. First, mGluR1 has been shown to negatively regulate CP-AMPAR levels in NAc synapses, and it is possible that a withdrawal-dependent decrease in this effect may help explain CP-AMPAR accumulation during incubation. Second, an increase in phosphorylation of GluA1 subunits (at the protein kinase A site) within extrasynaptic homomeric GluA1 receptors (CP-AMPARs) may promote their synaptic insertion and oppose their removal. Finally, elevation of brain-derived neurotrophic factor (BDNF) levels in the NAc may contribute to maintenance of incubation after months of withdrawal, although incubation-related increases in BDNF accumulation do not account for CP-AMPAR accumulation. Receptors and pathways that negatively regulate incubation, such as mGluR1, are promising targets for the development of therapeutic strategies to help recovering addicts maintain abstinence. This article is part of a Special Issue entitled 'NIDA 40th Anniversary Issue'.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BDNF; Cocaine; Incubation; Metabotropic glutamate receptor; Nucleus accumbens; Protein kinase A

Mesh:

Substances:

Year:  2013        PMID: 23727437      PMCID: PMC3836860          DOI: 10.1016/j.neuropharm.2013.04.061

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  165 in total

Review 1.  Putting a spin on the dorsal-ventral divide of the striatum.

Authors:  Pieter Voorn; Louk J M J Vanderschuren; Henk J Groenewegen; Trevor W Robbins; Cyriel M A Pennartz
Journal:  Trends Neurosci       Date:  2004-08       Impact factor: 13.837

Review 2.  BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis.

Authors:  Clive R Bramham; Elhoucine Messaoudi
Journal:  Prog Neurobiol       Date:  2005-06       Impact factor: 11.685

Review 3.  Presynaptic modulation by endocannabinoids.

Authors:  David M Lovinger
Journal:  Handb Exp Pharmacol       Date:  2008

4.  Region-specific alterations in glutamate receptor expression and subcellular distribution following extinction of cocaine self-administration.

Authors:  M Behnam Ghasemzadeh; Preethi Vasudevan; Christopher R Mueller; Chad Seubert; John R Mantsch
Journal:  Brain Res       Date:  2009-02-05       Impact factor: 3.252

Review 5.  Psychostimulant-induced neuroadaptations in nucleus accumbens AMPA receptor transmission.

Authors:  R Christopher Pierce; Marina E Wolf
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

6.  Extrasynaptic membrane trafficking regulated by GluR1 serine 845 phosphorylation primes AMPA receptors for long-term potentiation.

Authors:  Michael C Oh; Victor A Derkach; Eric S Guire; Thomas R Soderling
Journal:  J Biol Chem       Date:  2005-11-04       Impact factor: 5.157

7.  Comparative analysis of the subcellular and subsynaptic localization of mGluR1a and mGluR5 metabotropic glutamate receptors in the shell and core of the nucleus accumbens in rat and monkey.

Authors:  Darlene A Mitrano; Yoland Smith
Journal:  J Comp Neurol       Date:  2007-02-01       Impact factor: 3.215

Review 8.  The persistence of maladaptive memory: addiction, drug memories and anti-relapse treatments.

Authors:  Amy L Milton; Barry J Everitt
Journal:  Neurosci Biobehav Rev       Date:  2012-01-24       Impact factor: 8.989

Review 9.  New insights into the role of brain-derived neurotrophic factor in synaptic plasticity.

Authors:  Emily G Waterhouse; Baoji Xu
Journal:  Mol Cell Neurosci       Date:  2009-07-03       Impact factor: 4.314

10.  Nucleus accumbens neurons exhibit synaptic scaling that is occluded by repeated dopamine pre-exposure.

Authors:  Xiu Sun; Marina E Wolf
Journal:  Eur J Neurosci       Date:  2009-08-07       Impact factor: 3.386

View more
  63 in total

Review 1.  Motivational Processes Underlying Substance Abuse Disorder.

Authors:  Paul J Meyer; Christopher P King; Carrie R Ferrario
Journal:  Curr Top Behav Neurosci       Date:  2016

2.  Withdrawal From Cocaine Self-administration Alters the Regulation of Protein Translation in the Nucleus Accumbens.

Authors:  Michael T Stefanik; Mike Milovanovic; Craig T Werner; John C G Spainhour; Marina E Wolf
Journal:  Biol Psychiatry       Date:  2018-02-23       Impact factor: 13.382

3.  Intermittent intake of rapid cocaine injections promotes the risk of relapse and increases mesocorticolimbic BDNF levels during abstinence.

Authors:  Aliou B Gueye; Florence Allain; Anne-Noël Samaha
Journal:  Neuropsychopharmacology       Date:  2018-10-26       Impact factor: 7.853

4.  Functional consequences of cocaine re-exposure after discontinuation of cocaine availability.

Authors:  Thomas J R Beveridge; Hilary R Smith; Susan H Nader; Michael A Nader; Linda J Porrino
Journal:  Neuropharmacology       Date:  2014-06-19       Impact factor: 5.250

5.  Dampened Mesolimbic Dopamine Function and Signaling by Saturated but not Monounsaturated Dietary Lipids.

Authors:  Cecile Hryhorczuk; Marc Florea; Demetra Rodaros; Isabelle Poirier; Caroline Daneault; Christine Des Rosiers; Andreas Arvanitogiannis; Thierry Alquier; Stephanie Fulton
Journal:  Neuropsychopharmacology       Date:  2015-07-14       Impact factor: 7.853

6.  Gamma-Aminobutyric Acidergic Projections From the Dorsal Raphe to the Nucleus Accumbens Are Regulated by Neuromedin U.

Authors:  James M Kasper; David L McCue; Adrianna J Milton; Angelia Szwed; Catherine M Sampson; Mei Huang; Susan Carlton; Herbert Y Meltzer; Kathryn A Cunningham; Jonathan D Hommel
Journal:  Biol Psychiatry       Date:  2016-03-08       Impact factor: 13.382

7.  Dnmt3a2 in the Nucleus Accumbens Shell Is Required for Reinstatement of Cocaine Seeking.

Authors:  Nazzareno Cannella; Ana M M Oliveira; Thekla Hemstedt; Thomas Lissek; Elena Buechler; Hilmar Bading; Rainer Spanagel
Journal:  J Neurosci       Date:  2018-07-20       Impact factor: 6.167

8.  Incubation of methamphetamine and palatable food craving after punishment-induced abstinence.

Authors:  Irina N Krasnova; Nathan J Marchant; Bruce Ladenheim; Michael T McCoy; Leigh V Panlilio; Jennifer M Bossert; Yavin Shaham; Jean L Cadet
Journal:  Neuropsychopharmacology       Date:  2014-03-03       Impact factor: 7.853

9.  Role of Dorsal Striatum Histone Deacetylase 5 in Incubation of Methamphetamine Craving.

Authors:  Xuan Li; Maria B Carreria; Kailyn R Witonsky; Tamara Zeric; Olivia M Lofaro; Jennifer M Bossert; Jianjun Zhang; Felicia Surjono; Christopher T Richie; Brandon K Harvey; Hyeon Son; Christopher W Cowan; Eric J Nestler; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2017-12-29       Impact factor: 13.382

10.  A protein synthesis-dependent mechanism sustains calcium-permeable AMPA receptor transmission in nucleus accumbens synapses during withdrawal from cocaine self-administration.

Authors:  Andrew F Scheyer; Marina E Wolf; Kuei Y Tseng
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.